Sidana Ajeet
Department of Psychiatry, Government Medical College and Hospital, Chandigarh, India.
Indian J Psychol Med. 2018 Jan-Feb;40(1):91-92. doi: 10.4103/IJPSYM.IJPSYM_140_17.
To highlight the association between amisulpride and onset of tardive dyskinesia (TD) in patient suffering with psychosis not otherwise specified (NOS), who has already been treated with amisulpride for many years. A 40-year-old female suffering with psychosis NOS since 19 years presented with recurrence of positive symptoms in the form of delusion of persecution, ideas of grandiosity since last 3 months. She was treated with amisulpride up to 400 mg/day and developed involuntary oro-buccal-lingual movement within 2 months of amisulpride therapy. Amisulpride an atypical antipsychotic can lead to the development of TD in patient who already received amisulpride for many years in the past. Reexposure with amisulpride can lead to early onset of TD due to blockade of already unregulated postsynaptic supersensitive dopamine receptors.
为强调在未另行说明(NOS)的精神病患者中,阿立哌唑与迟发性运动障碍(TD)发作之间的关联,该患者已接受阿立哌唑治疗多年。一名40岁女性,自19岁起患有NOS型精神病,在过去3个月出现以被害妄想、夸大观念形式表现的阳性症状复发。她接受阿立哌唑治疗,剂量高达每日400毫克,在阿立哌唑治疗2个月内出现不自主的口-颊-舌运动。阿立哌唑作为一种非典型抗精神病药物,可导致过去已接受阿立哌唑治疗多年的患者发生TD。再次使用阿立哌唑可因阻断已不受调节的突触后超敏多巴胺受体而导致TD早发。